Page 805 - Read Online

Page 8 of 9 Calabrò et al. Hepatoma Res 2020;6:69 I http://dx.doi.org/10.20517/2394-5079.2020.63

11. Hamurcu Varol P, Kaya E, Alphan E, Yilmaz Y. Role of intensive dietary and lifestyle interventions in the treatment of lean nonalcoholic
fatty liver disease patients. Eur J Gastroenterol Hepatol 2020;32:1352-7.
12. Cai J, Zhang XJ, Li H. Progress and challenges in the prevention and control of nonalcoholic fatty liver disease. Med Res Rev
2019;39:328-48.
13. Abenavoli L, Di Renzo L, Boccuto L, Alwardat N, Gratteri S, et al. Health benefits of Mediterranean diet in nonalcoholic fatty liver
disease. Expert Rev Gastroenterol Hepatol 2018;12:873-81.
14. Abenavoli L, Boccuto L, Federico A, Dallio M, Loguercio C, et al. Diet and non-alcoholic fatty liver disease: the mediterranean way. Int J
Environ Res Public Health 2019;16:3011.
15. Abenavoli L, Milic N, Luzza F, Boccuto L, De Lorenzo A. Polyphenols Treatment in Patients with Nonalcoholic Fatty Liver Disease. J
Transl Int Med 2017;5:144-7.
16. Abenavoli L, Milic N, Di Renzo L, Preveden T, Medić-Stojanoska M, et al. Metabolic aspects of adult patients with nonalcoholic fatty
liver disease. World J Gastroenterol 2016;22:7006-16.
17. Di Renzo L, Cioccoloni G, Bernardini S, Abenavoli L, Aiello V, et al. A hazelnut-enriched diet modulates oxidative stress and
inflammation gene expression without weight gain. Oxid Med Cell Longev 2019;2019:4683723.
18. Araújo AR, Rosso N, Bedogni G, Tiribelli C, Bellentani S. Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic
steatohepatitis: what we need in the future. Liver Int 2018;38 Suppl 1:47-51.
19. Luk JM, Wang X, Liu P, Wong KF, Chan KL, et al. Traditional Chinese herbal medicines for treatment of liver fibrosis and cancer: from
laboratory discovery to clinical evaluation. Liver Int 2007;27:879-90.
20. Philips CA, Augustine P, Rajesh S, Y PK, Madhu D. Complementary and alternative medicine-related drug-induced liver injury in Asia. J
Clin Transl Hepatol 2019;7:263-74.
21. Richmond JA, Bailey DE, Patel K, Jezsik JA, Muir A, et al. The use of complementary and alternative medicine by patients with chronic
hepatitis C. Complement Ther Clin Pract 2010;16:124-31.
22. Henson JB, Brown CL, Chow SC, Muir AJ. Complementary and alternative medicine use in United States adults with liver disease. J Clin
Gastroenterol 2017;51:564-70.
23. Nieber K. The impact of coffee on health. Planta Med 2017;83:1256-63.
24. Costa J, Lunet N, Santos C, Santos J, Vaz-Carneiro A. Caffeine exposure and the risk of Parkinson’s disease: a systematic review and
meta-analysis of observational studies. J Alzheimers Dis 2010;20 Suppl 1:S221-38.
25. Crippa A, Discacciati A, Larsson SC, Wolk A, Orsini N. Coffee consumption and mortality from all causes, cardiovascular disease, and
cancer: a dose-response meta-analysis. Am J Epidemiol 2014;180:763-75.
26. Nordestgaard AT, Stender S, Nordestgaard BG, Tybjaerg-Hansen A. Coffee intake protects against symptomatic gallstone disease in the
general population: a Mendelian randomization study. J Intern Med 2020;287:42-53.
27. Lopez-Garcia E, van Dam RM, Li TY, Rodriguez-Artalejo F, Hu FB. The relationship of coffee consumption with mortality. Ann Intern
Med 2008;148:904-14.
28. Freedman ND, Park Y, Abnet CC, Hollenbeck AR, Sinha R. Association of coffee drinking with total and cause-specific mortality. N Engl
J Med 2012;366:1891-904.
29. Nehlig A, Daval J, Debry G. Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant
effects. Brain Res Rev 1992;17:139-70.
30. Shim SG, Jun DW, Kim EK, Saeed WK, Lee KN, et al. Caffeine attenuates liver fibrosis via defective adhesion of hepatic stellate cells in
cirrhotic model. J Gastroenterol Hepatol 2013;28:1877-84.
31. Gressner OA, Lahme B, Rehbein K, Siluschek M, Weiskirchen R, et al. Pharmacological application of caffeine inhibits TGF-beta-
stimulated connective tissue growth factor expression in hepatocytes via PPARgamma and SMAD2/3-dependent pathways. J Hepatol
2008;49:758-67.
32. Quan HY, Kim DY, Chung SH. Caffeine attenuates lipid accumulation via activation of AMP-activated protein kinase signaling pathway
in HepG2 cells. BMB Rep 2013;46:207-12.
33. Helal MG, Ayoub SE, Elkashefand WF, Ibrahim TM. Caffeine affects HFD-induced hepatic steatosis by multifactorial intervention. Hum
Exp Toxicol 2018;37:983-90.
34. Perumpail BJ, Li AA, Iqbal U, Sallam S, Shah ND, et al. Potential therapeutic benefits of Herbs and supplements in patients with
NAFLD. Diseases 2018;6:80.
35. Watanabe S, Takahashi T, Ogawa H, Uehara H, Tsunematsu T, et al. Daily coffee intake inhibits pancreatic beta cell damage and
nonalcoholic steatohepatitis in a mouse model of spontaneous metabolic syndrome, tsumura-suzuki obese diabetic mice. Metab Syndr
Relat Disord 2017;15:170-7.
36. Di Renzo L, Marsella LT, Carraro A, Valente R, Gualtieri P, et al. Changes in LDL oxidative status and oxidative and inflammatory gene
expression after red wine intake in healthy people: a randomized trial. Mediators Inflamm 2015;2015:317348.
37. Colica C, Di Renzo L, Trombetta D, Smeriglio A, Bernardini S, et al. Antioxidant effects of a hydroxytyrosol-based pharmaceutical
formulation on body composition, metabolic state, and gene expression: a randomized double-blinded, placebo-controlled crossover trial.
Oxid Med Cell Longev 2017;2017:2473495.
38. Meng S, Cao J, Feng Q, Peng J, Hu Y. Roles of chlorogenic acid on regulating glucose and lipids metabolism: a review. Evid Based
Complement Alternat Med 2013;2013:801457.
39. Zduńska K, Dana A, Kolodziejczak A, Rotsztejn H. Antioxidant properties of ferulic acid and its possible application. Skin Pharmacol
Physiol 2018;31:332-6.